Stay updated on Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial
Sign up to get notified when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.

Latest updates to the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoChange DetectedNew revision v3.6.6 for the study protocol and SAP has been added, replacing the earlier v3.6.5. The updated documents are now available in the Study Documents section.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision label on the page updates from v3.6.4 to v3.6.5, signaling a new site build. This is a technical version update rather than a modification to the study content or its results.SummaryDifference0.1%

- Check43 days agoChange DetectedThe page now displays Revision: v3.6.4 and no longer shows Revision: v3.6.3. This indicates the document or component has been updated to a newer revision without changing the trial details.SummaryDifference0.1%

- Check64 days agoChange DetectedFooter revision label updated to v3.6.3, replacing the previous v3.6.2. This indicates a deployment/update of the page.SummaryDifference0.1%

- Check72 days agoChange DetectedThe page revision was updated from v3.6.0 to v3.6.2, indicating a newer internal version. It appears to be an incremental revision to the underlying page materials rather than a change in visible content.SummaryDifference0.1%

- Check86 days agoChange DetectedNew help/navigation items were added to the study page, including How to Read a Study Record, Common Questions, How to Join a Study, and a merged Intervention/Treatment header. The older Intervention / Treatment label and the Revision: v3.5.5 note were removed, and the revision label updated to Revision: v3.6.0.SummaryDifference0.4%

Stay in the know with updates to Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Bictegravir vs Dolutegravir in HIV/HepB Co-Infection Clinical Trial page.